BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 37009320)

  • 1. Prevention of malignant digestive system tumors should focus on the control of chronic inflammation.
    Zhang YH; Chen XL; Wang YR; Hou YW; Zhang YD; Wang KJ
    World J Gastrointest Oncol; 2023 Mar; 15(3):389-404. PubMed ID: 37009320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai).
    Du Y; Zhu H; Liu J; Li J; Chang X; Zhou L; Chen M; Lu N; Li Z
    J Gastroenterol Hepatol; 2020 Apr; 35(4):624-629. PubMed ID: 31788864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of serum anti-Helicobacter pylori immunoglobulin G in patients with different digestive malignant tumors.
    Wang KX; Wang XF; Peng JL; Cui YB; Wang J; Li CP
    World J Gastroenterol; 2003 Nov; 9(11):2501-4. PubMed ID: 14606084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter-based mouse models of digestive system carcinogenesis.
    Rogers AB; Houghton J
    Methods Mol Biol; 2009; 511():267-95. PubMed ID: 19347301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactomedin-4 in digestive diseases: A mini-review.
    Wang XY; Chen SH; Zhang YN; Xu CF
    World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unpleasant Journey from Helicobacter pylori-associated Gastritis to Gastric Cancer: Cancer Prevention by Taking a Detour].
    Lee SH; Park JM; Han YM; Ko WJ; Hahm KB
    Korean J Gastroenterol; 2015 Dec; 66(6):303-11. PubMed ID: 26691187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER PRECURSOR LESIONS: PREVALENCE AND ASSOCIATED FACTORS IN A REFERENCE LABORATORY IN SOUTHEASTERN BRAZIL.
    Rodrigues MF; Guerra MR; Alvarenga AVR; Souza DZO; Costa RAVES; Cupolilo SMN
    Arq Gastroenterol; 2019; 56(4):419-424. PubMed ID: 31800739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between
    Xu W; Xu L; Xu C
    Front Cell Infect Microbiol; 2022; 12():938608. PubMed ID: 36061875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review.
    Shah SC; Piazuelo MB; Kuipers EJ; Li D
    Gastroenterology; 2021 Oct; 161(4):1325-1332.e7. PubMed ID: 34454714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mortality from malignant tumors of the digestive system in an area of the province of Milan from 1980 to 1987].
    Macchi C; Mongiat R; Pellino P
    Ann Ig; 1989; 1(6):1573-86. PubMed ID: 2484489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori screening: options and challenges.
    Venerito M; Goni E; Malfertheiner P
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):497-503. PubMed ID: 26619972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Helicobacter pylori eradication on gastric cancer incidence in the Japanese population: a systematic evidence review.
    Lin Y; Kawai S; Sasakabe T; Nagata C; Naito M; Tanaka K; Sugawara Y; Mizoue T; Sawada N; Matsuo K; Kitamura T; Utada M; Ito H; Shimazu T; Kikuchi S; Inoue M;
    Jpn J Clin Oncol; 2021 Jul; 51(7):1158-1170. PubMed ID: 33893508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mortality due to digestive and hepatobiliary diseases in Peru, 1995 - 2000].
    Farfán G; Cabezas C
    Rev Gastroenterol Peru; 2002; 22(4):310-23. PubMed ID: 12525847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCR in Helicobacter spp. diagnostic in extragastric malignancies of digestive system.
    Bulajic M; Panic N; Stimec B; Isaksson B; Jesenofsky R; Schneider-Brachert W; Löhr JM
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):117-25. PubMed ID: 22081011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenetics and pathogenesis of gastric cancer. Highlights of the First Sino-European Workshop on the Immunogenetics and Pathogenesis of Gastric Cancer.
    Wu K; Crusius JB; Fan D; Peña AS
    Drugs Today (Barc); 2002 Jun; 38(6):391-417. PubMed ID: 12532177
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.